Key Highlights

  • CBIH shares are trading 42.86% higher on Wednesday, October 28, 2026, at a quote below one cent.
  • The company has 11,626,749,347 common shares outstanding as of April 16, 2026.
  • Revenue for the quarter ended February 28, 2026 was $11,205, down from $14,931 a year earlier.
  • Cash stood at $90 on February 28, 2026, against total liabilities of $1,468,674.
  • The first VitaCookies licensing agreement was announced on June 22, 2026, and a Texas hemp license on July 15, 2026.

Cannabis Bioscience International Holdings Move: Why Is a Sub-Cent Stock Among the Most Active Today?

Cannabis Bioscience International Holdings (OTC:CBIH) shares are trading 42.86% higher on Wednesday, October 28, 2026, with the quote still below one cent. The stock ranks among the most heavily traded penny stocks of the session, yet no company release dated October 28 accompanies the move. On quotes this small, a single price increment can produce a double-digit percentage change.

The company trades on the OTC Markets. Its two most recent releases, a first VitaCookies licensing agreement and a Texas hemp license, were issued this summer and supply commercial context, though neither is dated today.

Cannabis Bioscience International Holdings provides educational systems on medical cannabis in the United States and clinical trial services, and is developing cannabidiol-based products.

VitaCookies Licensing and the Texas Hemp License: What Did the Company Announce?

On June 22, 2026, the company announced its first VitaCookies licensing agreement for its functional wellness cookie brand. The licensee, NCAS, a Dallas-based operator, will run the first locations in Dallas and Houston, and Mexico City is being evaluated as a possible international entry point.

The release disclosed no dollar amounts, royalty structure, duration or exclusivity terms, and said any product activity depends on approvals, permits, labeling, laboratory testing and compliance in each jurisdiction.

On July 15, 2026, the company announced that Texas had approved its license to manufacture and distribute consumable hemp products, with initial distribution expected within 30 days. The release called VitaCookies the first commercial product of its integrated model.

Going-Concern Warning: Can $90 in Cash and 11.6 Billion Shares Fund Expansion?

The latest quarterly report covers the three months ended February 28, 2026. Revenue was $11,205, down from $14,931 a year earlier, and the net loss narrowed to $103,933 from $181,243. Nine-month revenue was $88,671.

Cash was $90, down from $12,952 at May 31, 2025. Total liabilities were $1,468,674, the working capital deficit was $1,217,630 and the accumulated deficit was $6,186,448.

The filing states that recurring losses, negative working capital and negative operating cash flows raise substantial doubt about the company's ability to continue as a going concern. On March 20, 2026, it issued 20 million shares for professional services, valued at $5,000, or $0.00025 per share.

With so many shares, even a price of one-tenth of a cent would imply a market value of roughly $11.6 million (calculated).

What to Watch Next: Licensing Terms, Hemp Distribution and the Next Quarterly Filing

Investors can watch for disclosure of VitaCookies licensing terms, confirmation that Texas hemp distribution has begun, and progress on Mexico City. The next quarterly filing will show whether revenue, cash, liabilities and the share count have moved since February 28, 2026. Until a dated release explains today's activity, the move rests on trading volume in a sub-cent quote.